Sentences with phrase «patient data in a study»

Not exact matches

FITBIT DATA AIDS RESEARCHERS IN UNDERSTANDING SURGERY RECOVERY: Fitbit data can help researchers and doctors predict the risk of 30 - and 60 - day readmission after surgery for cancer patients, according to a study published in the Annals of Behavioral MedicinIN UNDERSTANDING SURGERY RECOVERY: Fitbit data can help researchers and doctors predict the risk of 30 - and 60 - day readmission after surgery for cancer patients, according to a study published in the Annals of Behavioral Medicinin the Annals of Behavioral Medicine.

But Amgen's rivals in the space, Sanofi and Regeneron (which have their own PCSK9 blocking medicine called Praluent), announced that an independent data monitoring committee hasn't seen enough significant evidence in a huge, 18,000 - patient cardiovascular outcomes trial to stop the study early.

The ENDEAVOUR Phase 3 study data monitoring committee recommended dosing be suspended after it found «an imbalance of mortality» in patients who used revusiran as compared to placebo.

Khosla referenced a study that asked a group of doctors to review patient data in order to determine whether the individual was in need of cardiac surgery.

«Among both groups, patients taking Entresto had a 20 % or greater reduction in cardiovascular death or heart failure hospitalization compared to those taking enalapril,» Novartis said in a statement, citing conclusions based on analysis of data from the PARADIGM - HF study.

Final patient visits will be followed by completing data entry for the more than 35,000 patient years of study in REDUCE - IT, and typical database quality control measures, known as cleaning.

These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).

25,000 patients will be enrolled in the first study ever to combine data from genetics, cognitive tests and online surveys to explore how genetics is related to Major Depressive Disorder, Bipolar Depression and certain brain functions.

The biotech specialist said that its updated phase 2 data in a study of its poziotinib candidate treatment for non-small cell lung cancer resulted in a preliminary confirmed objective response rate and potential progression - free survival benefit in patients with the EGFR Exon 20 Mutant form of the disease.

The last patient enrolled in this study in October 2016, and it sure looks as if investors a bit too eager to call this one a win rather than wait for the final data set.

Even in IBD patients, who have a very messed up microbiome (a finding of the American Gut data), the benefits of antioxidant therapy is well documented (see below studies).

For example, the fact that 27 transfer patients are listed as having a physician as their planned birth attendant is most likely due to errors in birth - certificate completion; data are currently lacking to inform the degree of misclassification related to this and others factors that affect the study outcomes.

For the purposes of this economic evaluation, the forms were initially used in a related study funded by the National Institute of Health Research (NIHR) research for patient benefit programme «assessing the impact of a new birth centre on choice and outcome of maternity care in an inner city area,» which will be reported in full elsewhere, comparing the costs of care in a free standing midwifery unit with care in an obstetric unit in the same trust.16 The data collected included details of staffing levels, treatments, surgeries, diagnostic imaging tests, scans, drugs, and other resource inputs associated with each stage of the pathway through intrapartum and after birth care.

This study provides detailed anaesthetic and peripartum management of women with congenital heart disease, a patient population in whom evidence - based practice and data are largely lacking.

Additional data from this study, also presented at The International Liver CongressTM today in Barcelona, Spain, show that 97 % of patients with the same HCV genotype, but without scarred livers, achieved SVR12 after eight weeks on the same treatment without ribavirin (RBV).

Of the patients who received the high dose in study, 11 patients are able to speak, 11 patients are fed orally and seven do not require bi-level positive airway pressure as of the data cut - off (August 7, 2017).

To conduct this work, Drs. Carmen Black and Brian Miller at Georgia Regents University collected and pooled data from 18 published studies, resulting in a combined total of 583 psychiatric patients with suicidality, 315 psychiatric patients without suicidality and 845 healthy control subjects.

As data on proton treatments continued to dribble in, it was hard for Zietman to accept the implications of his own studies, which tracked patients» progress.

While based on nationwide data, the study was limited to patients in the VA system, who may differ from the general population of ulcerative colitis patients.

The authors are especially concerned about the risks of posting data from small studies or series of patients from a few hospitals — a type of data commonly used for research in anesthesiology and surgery.

«Data from this study serves as rationale to now include dogs with spontaneous cancers in the advancement and optimization of PMed for human patients,» according to the study, Prospective molecular profiling of canine cancers provides a clinically relevant comparative model for evaluating personalized medicine (PMed) trials.

Using data from the National Health and Nutrition Examination Survey, Dr. Ho and his colleagues studied cases of psoriasis and depression in a pool of 12,382 adult patients.

The study used nationwide data on 836 patients newly diagnosed with ulcerative colitis in the Veterans Affairs (VA) health care system from 2001 to 2011.

In this new work, BIDMC researchers and co-lead authors Sarinnapha M. Vasunilashorn, PhD, and Long Ngo, PhD, examined data from a patient cohort called SAGES (Successful Aging after Elective Surgery Study).

Key findings in this study show that 5 - year survival for older lung cancer surgery patients is favorable; surgeons will be able to better individualize care for older lung cancer patients based on newly and uniquely linked data, and the prevalence of lung cancer is expected to increase as the population continues to age.

In a study of national data on colon surgery, Johns Hopkins researchers found that while patients who undergo either minimally invasive laparoscopic surgery or the high - tech robotic approach have similar outcomes, robotic surgery is significantly more expensive.

In addition to this limitation, the study involved patients at a single hospital and could not control for all possible influences on heart attack risk since data relied on medical records of past heart attacks.

Patients with epilepsy often have ECoG arrays temporarily implanted in their brains to determine the location in the brain of epileptic seizures, so the scientists were able to study all the data collected from five such patients on healthy, seizure - freePatients with epilepsy often have ECoG arrays temporarily implanted in their brains to determine the location in the brain of epileptic seizures, so the scientists were able to study all the data collected from five such patients on healthy, seizure - freepatients on healthy, seizure - free nights.

These genomic variations have been revealed by studies in the population and by analysis of the genomes of colon cancer patients that are available in data bases such as that of the 1000 Genomes Project Ddata bases such as that of the 1000 Genomes Project DataData.

In the current study, Zhang and her colleagues, including Esther John, Ph.D., senior cancer epidemiologist at the Cancer Prevention Institute of California, analyzed data on 6,235 American and Canadian breast cancer patients from the Breast Cancer Family Registry, a National Cancer Institute - funded program that has collected clinical and questionnaire data on enrolled participants and their families since 1995.

In order to assess whether an improved diet could reduce the risk of ovarian cancer in African - American women, Qin analyzed the diets of 415 women with ovarian cancer and 629 control patients, using data from the African - American Cancer Epidemiology Study, a population - based case - control study of ovarian cancer in African - American women in 11 sites in the United StateIn order to assess whether an improved diet could reduce the risk of ovarian cancer in African - American women, Qin analyzed the diets of 415 women with ovarian cancer and 629 control patients, using data from the African - American Cancer Epidemiology Study, a population - based case - control study of ovarian cancer in African - American women in 11 sites in the United Statein African - American women, Qin analyzed the diets of 415 women with ovarian cancer and 629 control patients, using data from the African - American Cancer Epidemiology Study, a population - based case - control study of ovarian cancer in African - American women in 11 sites in the United StStudy, a population - based case - control study of ovarian cancer in African - American women in 11 sites in the United Ststudy of ovarian cancer in African - American women in 11 sites in the United Statein African - American women in 11 sites in the United Statein 11 sites in the United Statein the United States.

It could be some of the patients included in the study had non-VA hospital stays that were overlooked in the data.

In a study that included children and young adults with relapsed or refractory cancer, incorporation of integrative clinical genomic sequencing data into clinical management was feasible, revealed potentially actionable findings in nearly half of the patients, and was associated with change in treatment and family genetics counseling for a small proportion of patients, according to a study in the September 1 issue of JAMIn a study that included children and young adults with relapsed or refractory cancer, incorporation of integrative clinical genomic sequencing data into clinical management was feasible, revealed potentially actionable findings in nearly half of the patients, and was associated with change in treatment and family genetics counseling for a small proportion of patients, according to a study in the September 1 issue of JAMin nearly half of the patients, and was associated with change in treatment and family genetics counseling for a small proportion of patients, according to a study in the September 1 issue of JAMin treatment and family genetics counseling for a small proportion of patients, according to a study in the September 1 issue of JAMin the September 1 issue of JAMA.

Although the study sample is small, these data suggest that glutamate levels in the LDLPFC are associated with alcohol - craving intensity in patients with AUDs.

The study examined 328 patients with cervical cancer and 1,312 controls, matched on age and decade, who enrolled in a hospital - based case - control study drawn from 26,831 patients who received treatment at Roswell Park Cancer Institute and completed the Patient Epidemiology Data System questionnaire between 1982 and 1998.

In their study, Fiona Havers, MD, MHS, and a team from the Centers for Disease Control and Prevention and several other institutions analyzed data for approximately 6,800 patients with acute respiratory illness who were seen at five outpatient care centers in Washington state, Wisconsin, Texas, Michigan, and PennsylvaniIn their study, Fiona Havers, MD, MHS, and a team from the Centers for Disease Control and Prevention and several other institutions analyzed data for approximately 6,800 patients with acute respiratory illness who were seen at five outpatient care centers in Washington state, Wisconsin, Texas, Michigan, and Pennsylvaniin Washington state, Wisconsin, Texas, Michigan, and Pennsylvania.

Researchers studied data from 2,279 heart failure patients in a trial called Heart Failure: A Controlled Trial Investigating Outcomes of Exercise Training (HF - ACTION).

And no empirical data has tied researchers» financial interests in a study to negative outcomes for patients.

Treatment data of 871 episodes in 185 patients were entered into the study.

The data used in the study are from the Michigan Health and Hospital Association's Michigan Inpatient Database, which includes data on all hospital stays no matter what the insurance status of the patient.

The researchers analyzed data collected between 2002 and 2011 from patients in the Rochester Epidemiology Project, a National Institutes of Health - funded medical records pool that makes Olmsted County, Minn., the home of Mayo Clinic, one of the few places worldwide where scientists can study virtually an entire geographic population to identify health trends.

The study is based on data gathered from nearly 900,000 patient hospitalization records in Massachusetts, New York, New Jersey and Pennsylvania.

The study analysed data from 424 million visits made to emergency departments in the USA by patients aged 18 to 64 between 2005 and 2011.

In the retrospective study, Meropol and co-authors Allison A. Haupt, MSPH, and Sara M. Debanne, PhD, both from Case Western Reserve University School of Medicine, analyzed medical data from nearly 94,000 patients under the age of 18 years diagnosed with Enterobacteriaceae - associated infections at 48 children's hospitals throughout the US.

In one study that examined data from over 38 million inpatients in North America, Devereaux and his colleagues determined that patients treated at investor - owned, private for - profit hospitals had a significantly higher risk of dyinIn one study that examined data from over 38 million inpatients in North America, Devereaux and his colleagues determined that patients treated at investor - owned, private for - profit hospitals had a significantly higher risk of dyinin North America, Devereaux and his colleagues determined that patients treated at investor - owned, private for - profit hospitals had a significantly higher risk of dying.

Using data from the biologic agent study, they identified 252 verifiable first heart attack among these patients, including 58 in 3,058 patients using traditional DMARDs and 194 in 11,200 patients using biologic agents.

In the study, researchers examined private insurance claims data from more than 53,000 patients visiting U.S. emergency departments for an ankle sprain in 2011 - 201In the study, researchers examined private insurance claims data from more than 53,000 patients visiting U.S. emergency departments for an ankle sprain in 2011 - 201in 2011 - 2012.

Over time, patients end up providing a wealth of information to their health care providers, and when all our data are aggregated, they are also a boon to researchers studying trends in diseases and demographics for clues in how to better treat illness.

Boyle and colleagues used data from a case - control study conducted between 2000 and 2004 in British Columbia (BC), which recruited 820 NHL patients (59 percent men) of various ages from the B.C. Cancer Registry and 848 randomly selected controls matched for age, gender, and residential location, from the Client Registry of the British Columbia Ministry of Health.

The study analyzed data regarding surgical outcomes — complications, serious complications, and mortality — in over 345,000 patients treated between 2009 and 2013 at academic hospitals throughout the United States.